Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.

Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Asada H, Yamanishi K, Iso H.

J Epidemiol. 2015;25(10):617-25. doi: 10.2188/jea.JE20140210. Epub 2015 Sep 19.

2.

The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during Aging.

Vukmanovic-Stejic M, Sandhu D, Seidel JA, Patel N, Sobande TO, Agius E, Jackson SE, Fuentes-Duculan J, Suárez-Fariñas M, Mabbott NA, Lacy KE, Ogg G, Nestle FO, Krueger JG, Rustin MH, Akbar AN.

J Invest Dermatol. 2015 Jul;135(7):1752-62. doi: 10.1038/jid.2015.63. Epub 2015 Mar 3.

3.

Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States.

Suaya JA, Chen SY, Li Q, Burstin SJ, Levin MJ.

Open Forum Infect Dis. 2014 Aug 2;1(2):ofu049. doi: 10.1093/ofid/ofu049. eCollection 2014 Sep.

4.

Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.

Meyer C, Engelmann F, Arnold N, Krah DL, ter Meulen J, Haberthur K, Dewane J, Messaoudi I.

J Virol. 2015 Feb;89(3):1781-93. doi: 10.1128/JVI.03124-14. Epub 2014 Nov 19.

5.

Disseminated herpes zoster ophthalmicus in an immunocompetent 8-year old boy.

Oladokun RE, Olomukoro CN, Owa AB.

Clin Pract. 2013 May 20;3(2):e16. doi: 10.4081/cp.2013.e16. eCollection 2013 Aug 2.

6.

Successes and challenges in varicella vaccine.

Papaloukas O, Giannouli G, Papaevangelou V.

Ther Adv Vaccines. 2014 Mar;2(2):39-55. doi: 10.1177/2051013613515621. Review.

7.

Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.

Ogunjimi B, Smits E, Heynderickx S, Van den Bergh J, Bilcke J, Jansens H, Malfait R, Ramet J, Maecker HT, Cools N, Beutels P, Van Damme P.

Clin Vaccine Immunol. 2014 Mar;21(3):417-26. doi: 10.1128/CVI.00818-13. Epub 2014 Jan 15.

8.

Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine.

Levin MJ, Schmader KE, Gnann JW, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J.

J Infect Dis. 2013 Nov 1;208(9):1386-90. doi: 10.1093/infdis/jit342. Epub 2013 Aug 1.

9.

T-cell immunity to human alphaherpesviruses.

Ouwendijk WJ, Laing KJ, Verjans GM, Koelle DM.

Curr Opin Virol. 2013 Aug;3(4):452-60. doi: 10.1016/j.coviro.2013.04.004. Epub 2013 May 8. Review.

10.

Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjects.

Tyring SK, Stek JE, Smith JG, Xu J, Pagnoni M, Chan IS, Silber JL, Parrino J, Levin MJ.

Clin Vaccine Immunol. 2012 Sep;19(9):1411-5. doi: 10.1128/CVI.00095-12. Epub 2012 Jul 11.

11.

Integration of immunity with physical and cognitive function in definitions of successful aging.

Griffin P, Michel JJ, Huysman K, Logar AJ, Vallejo AN.

Aging Dis. 2012 Feb;3(1):34-50. Epub 2012 Feb 27.

12.

Simian varicella virus infection of Chinese rhesus macaques produces ganglionic infection in the absence of rash.

Ouwendijk WJ, Mahalingam R, Traina-Dorge V, van Amerongen G, Wellish M, Osterhaus AD, Gilden D, Verjans GM.

J Neurovirol. 2012 Apr;18(2):91-9. doi: 10.1007/s13365-012-0083-4. Epub 2012 Mar 8.

13.

Immune aging and challenges for immune protection of the graying population.

Vallejo AN.

Aging Dis. 2011 Oct;2(5):339-45. Epub 2011 Oct 28. No abstract available.

14.

Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.

Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J.

Clin Infect Dis. 2012 Apr;54(7):922-8. doi: 10.1093/cid/cir970. Epub 2012 Jan 30.

15.

Immune correlates of herpes zoster in HIV-infected children and youth.

Weinberg A, Huang S, Song LY, Fenton T, Williams P, Patterson J, Tovar-Salazar A, Levin MJ.

J Virol. 2012 Mar;86(5):2878-81. doi: 10.1128/JVI.06623-11. Epub 2011 Dec 14.

16.

Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancer.

Frazer IH, Levin MJ.

Curr Opin Virol. 2011 Oct;1(4):268-79. doi: 10.1016/j.coviro.2011.07.007. Review.

Items per page

Supplemental Content

Write to the Help Desk